当前位置： SCI文献检索 > EXPERIMENTAL CELL RESEARCH期刊下所有文献 > PKC 412 sensitizes U1810 non-small cell lung cancer cells to DNA damage.

PKC 412 sensitizes U1810 non-small cell lung cancer cells to DNA damage.

Abstract：

:Non-small cell lung carcinoma (NSCLC) is characterized by resistance to drug-induced apoptosis, which might explain the survival of lung cancer cells following treatment. Recently we have shown that the broad-range kinase inhibitor staurosporine (STS) reactivates the apoptotic machinery in U1810 NSCLC cells [Joseph et al., Oncogene 21 (2002) 65]. Lately, several STS analogs that are more specific in kinase inhibition have been suggested for tumor treatment. In this study the apoptosis-inducing ability of the STS analogs PKC 412 and Ro 31-8220 used alone or in combination with DNA-damaging agents in U1810 cells was investigated. In these cells Ro 31-8220 neither induced apoptosis when used alone, nor sensitized cells to etoposide treatment. PKC 412 as a single agent induced death of a small number of U1810 cells, whereas it efficiently triggered a dose- and time-dependent apoptosis in U1285 small cell lung carcinoma cells. In both cell types PKC 412 triggered release of mitochondrial proteins followed by caspase activation. However, concomitant activation of a caspase-independent pathway was essential to kill NSCLC cells. Importantly, PKC 412 was able to sensitize etoposide- and radiation-induced death of U1810 cells. The best sensitization was achieved when PKC 412 was administered 24 h after treatments. In U1810 cells, Ro 31-8220 decreased PMA-induced ERK phosphorylation as efficiently as PKC 412, indicating that the failure of Ro 31-8220 to induce apoptosis was not due to weaker inhibition of conventional and novel PKC isoforms. However, Ro 31-8220 increased the basal level of ERK and Akt phosphorylation in both cell lines, whereas Akt phosphorylation was suppressed in the U1810 cells, which might influence apoptosis. These results suggest that PKC 412 could be a useful tool in increasing the efficiency of therapy of NSCLC.

journal_name

Exp Cell Res

journal_title

Experimental cell research

authors

Hemström TH,Joseph B,Schulte G,Lewensohn R,Zhivotovsky B

doi

10.1016/j.yexcr.2004.12.017

keywords:

subject

Has Abstract

pub_date

2005-04-15 00:00:00

pages

200-13

issue

eissn

0014-4827

issn

1090-2422

pii

S0014-4827(04)00747-5

journal_volume

305

pub_type

杂志文章

在线工具

PKC 412 sensitizes U1810 non-small cell lung cancer cells to DNA damage.